Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer

We conducted a prospective, observational study of aspirin and COX-2 inhibitor use and survival in stage III colon cancer patients enrolled in an adjuvant chemotherapy trial. Among 799 eligible patients, aspirin use was associated with improved recurrence-free survival (RFS) (multivariable hazard ra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Natl Cancer Inst
Hauptverfasser: Ng, Kimmie, Meyerhardt, Jeffrey A., Chan, Andrew T., Sato, Kaori, Chan, Jennifer A., Niedzwiecki, Donna, Saltz, Leonard B., Mayer, Robert J., Benson, Al B., Schaefer, Paul L., Whittom, Renaud, Hantel, Alexander, Goldberg, Richard M., Venook, Alan P., Ogino, Shuji, Giovannucci, Edward L., Fuchs, Charles S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2014
Schlagworte:
Brief Communication
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271076/
https://ncbi.nlm.nih.gov/pubmed/25432409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju345
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge